Abstract
The RASCAD trial investigated the potential benefit of renal artery revascularization versus medical therapy in patients with renal artery stenosis and coronary artery disease. Surprisingly, renal artery stenting seemed to convey no benefit on left ventricular mass. Has all been said and done about renal artery revascularization?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.